{"id":39673,"date":"2026-04-28T09:58:07","date_gmt":"2026-04-28T07:58:07","guid":{"rendered":"https:\/\/immunostep.com\/?p=39673"},"modified":"2026-04-07T10:31:39","modified_gmt":"2026-04-07T08:31:39","slug":"off-the-shelf-cell-therapies","status":"publish","type":"post","link":"https:\/\/immunostep.com\/es\/2026\/04\/28\/off-the-shelf-cell-therapies\/","title":{"rendered":"Off-the-Shelf Cell Therapies: Current Status and Challenges"},"content":{"rendered":"

Cell therapies<\/strong> have transformed immuno-oncology and regenerative medicine, with autologous CAR-T therapies<\/a><\/strong> being the most recognized for their clinical efficacy. However, the need for fast, scalable, and cost-effective treatments<\/strong> has driven the development of \u201coff-the-shelf<\/strong>\u201d cell therapies,<\/a> also known as allogeneic or universal therapies<\/strong>. These approaches aim to overcome the limitations of autologous therapies by providing cells ready for multiple patients<\/strong>, reducing production time, and increasing product consistency.<\/p>\n

Autologous, Allogeneic, and Universal: Key Differences<\/h2>\n

Autologous therapies, derived from the patient\u2019s own cells, offer high compatibility and low immunogenicity. However, they require individualized manufacturing, leading to significant delays and high costs.<\/p>\n

Allogeneic therapies use donor cells, which are immediately available. This allows rapid access, although they carry a higher risk of immune rejection and graft-versus-host disease (GVHD). Universal therapies take this further by combining genetic editing to remove or modify HLA antigens<\/strong> and immunogenic receptors<\/strong>. This creates cells capable of evading the immune response and being administered to multiple patients without significant rejection.<\/p>\n

Genetic Editing and Immune Evasion<\/h2>\n

The main challenge for \u201coff-the-shelf\u201d therapies is the host immune response<\/strong>.\u00a0To mitigate this, researchers apply advanced HLA editing strategies, such as knocking out HLA class I\/II and expressing NK-inhibitory molecules like HLA-E. These modifications allow therapeutic cells to remain functional without being rapidly eliminated.<\/p>\n

Additionally, TCR receptor editing<\/strong> and removal of allogeneic antigens<\/strong> create \u201cinvisible<\/strong>\u201d cells to the immune system while maintaining their cytotoxic or regenerative capacity<\/strong>.<\/p>\n

Current Clinical Development<\/h2>\n

Currently, there are allogeneic and universal candidates<\/strong> in Phase I and II trials<\/strong>, primarily in hematology and solid tumors. Preliminary results indicate that it is possible to:<\/p>\n

    \n
  • Reduce production times<\/strong> from weeks to days.<\/li>\n
  • Maintain comparable efficacy<\/strong> to autologous therapies in selected patients.<\/li>\n
  • Require combined strategies of immunosuppression<\/strong> and HLA editing<\/strong> to minimize rejection.<\/li>\n<\/ul>\n

    Nevertheless, researchers still need to conduct long-term studies to assess cell persistence, toxicity, and adverse events associated with immune evasion.<\/strong><\/p>\n

    Challenges and Future Perspectives<\/h2>\n

    The main challenges include:<\/p>\n

      \n
    • Precise control of genetic editing<\/strong> to avoid off-target mutations.<\/li>\n
    • Optimization of scalable and reproducible manufacturing<\/strong>.<\/li>\n
    • Balancing immune evasion<\/strong> with patient safety<\/strong>.<\/li>\n
    • Achieving regulatory approval and clinical acceptance<\/strong> in different markets.<\/li>\n<\/ul>\n

      The combination of advanced cellular engineering<\/strong> and immune evasion strategies<\/strong> promises to overcome current limitations and open new opportunities in immunotherapy and regenerative medicine<\/strong>.<\/p>\n

      Comparative Infographic: Autologous vs Allogeneic vs Universal<\/h2>\n

      The following infographic<\/strong> summarizes the comparison:<\/p>\n\n\n\n\n\n\n\n\n\n
      Characteristic<\/th>\nAutologous<\/th>\nAllogeneic<\/th>\nUniversal<\/th>\n<\/tr>\n<\/thead>\n
      Cell Source<\/td>\nPatient<\/td>\nDonor<\/td>\nGenetically modified \/ engineered lines<\/td>\n<\/tr>\n
      Production Time<\/td>\nWeeks<\/td>\nDays<\/td>\nDays<\/td>\n<\/tr>\n
      Risk of Rejection<\/td>\nMinimal<\/td>\nHigh<\/td>\nControlled by HLA editing<\/td>\n<\/tr>\n
      Immune Evasion<\/td>\nNot required<\/td>\nLimited<\/td>\nOptimized (HLA-KO, HLA-E, TCR-KO)<\/td>\n<\/tr>\n
      Scalability<\/td>\nLow<\/td>\nMedium<\/td>\nHigh<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

      Cell therapies have transformed immuno-oncology and regenerative medicine, with autologous CAR-T therapies being the most recognized for their clinical efficacy. However, the need for fast, scalable, and cost-effective treatments has driven the development of \u201coff-the-shelf\u201d cell therapies, also known as allogeneic or universal therapies. These approaches aim to overcome the limitations of autologous therapies by […]<\/p>\n","protected":false},"author":225,"featured_media":39676,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[2033],"tags":[2545,2544,2469,2547,2548,2506,2549,2546,2031,2283],"class_list":["post-39673","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-immunology","tag-allogeneiccells","tag-autologouscells","tag-celltherapy","tag-hlaediting","tag-immuneevasion","tag-offtheshelftherapy","tag-regenerativemedicine","tag-universalcells","tag-car-t","tag-immunotherapy"],"yoast_head":"\nOff-the-Shelf Cell Therapies: Current Status and Challenges | Immunostep Biotech<\/title>\n<meta name=\"description\" content=\"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.-Cell therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Off-the-Shelf Cell Therapies: Current Status and Challenges | Immunostep Biotech\" \/>\n<meta property=\"og:description\" content=\"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.-Cell therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"Immunostep Biotech\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/immunostepsl\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-28T07:58:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-07T08:31:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/immunostep.com\/wp-content\/uploads\/2026\/04\/Off-the-Shelf-Cell-Therapies-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"290\" \/>\n\t<meta property=\"og:image:height\" content=\"174\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c1ngela Cabestrero\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Immunostep\" \/>\n<meta name=\"twitter:site\" content=\"@Immunostep\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c1ngela Cabestrero\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/\"},\"author\":{\"name\":\"\u00c1ngela Cabestrero\",\"@id\":\"https:\/\/immunostep.com\/#\/schema\/person\/6f7086a7900eb41588a2465bcae5f427\"},\"headline\":\"Off-the-Shelf Cell Therapies: Current Status and Challenges\",\"datePublished\":\"2026-04-28T07:58:07+00:00\",\"dateModified\":\"2026-04-07T08:31:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/\"},\"wordCount\":435,\"publisher\":{\"@id\":\"https:\/\/immunostep.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2026\/04\/Off-the-Shelf-Cell-Therapies-1.jpg\",\"keywords\":[\"#AllogeneicCells\",\"#AutologousCells\",\"#CellTherapy\",\"#HLAEditing\",\"#ImmuneEvasion\",\"#OffTheShelfTherapy\",\"#RegenerativeMedicine\",\"#UniversalCells\",\"CAR T\",\"immunotherapy\"],\"articleSection\":[\"Immunology\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/\",\"url\":\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/\",\"name\":\"Off-the-Shelf Cell Therapies: Current Status and Challenges | Immunostep Biotech\",\"isPartOf\":{\"@id\":\"https:\/\/immunostep.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2026\/04\/Off-the-Shelf-Cell-Therapies-1.jpg\",\"datePublished\":\"2026-04-28T07:58:07+00:00\",\"dateModified\":\"2026-04-07T08:31:39+00:00\",\"description\":\"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.-Cell therapies.\",\"breadcrumb\":{\"@id\":\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#primaryimage\",\"url\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2026\/04\/Off-the-Shelf-Cell-Therapies-1.jpg\",\"contentUrl\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2026\/04\/Off-the-Shelf-Cell-Therapies-1.jpg\",\"width\":290,\"height\":174,\"caption\":\"Off-the-Shelf Cell Therapies\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/immunostep.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Off-the-Shelf Cell Therapies: Current Status and Challenges\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/immunostep.com\/#website\",\"url\":\"https:\/\/immunostep.com\/\",\"name\":\"Immunostep Biotech\",\"description\":\"Innovating to deliver high-performance technology for Research and Diagnosis\",\"publisher\":{\"@id\":\"https:\/\/immunostep.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/immunostep.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/immunostep.com\/#organization\",\"name\":\"Immunostep Biotech\",\"url\":\"https:\/\/immunostep.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/immunostep.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2021\/10\/logo-web-color.png\",\"contentUrl\":\"https:\/\/immunostep.com\/wp-content\/uploads\/2021\/10\/logo-web-color.png\",\"width\":1299,\"height\":591,\"caption\":\"Immunostep Biotech\"},\"image\":{\"@id\":\"https:\/\/immunostep.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/immunostepsl\/\",\"https:\/\/x.com\/Immunostep\",\"https:\/\/www.linkedin.com\/company\/immunostepsl\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/immunostep.com\/#\/schema\/person\/6f7086a7900eb41588a2465bcae5f427\",\"name\":\"\u00c1ngela Cabestrero\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/immunostep.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/378033e78b9b0300f6f50aeac830c5cf?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/378033e78b9b0300f6f50aeac830c5cf?s=96&d=mm&r=g\",\"caption\":\"\u00c1ngela Cabestrero\"},\"url\":\"https:\/\/immunostep.com\/es\/author\/acabestrero\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Off-the-Shelf Cell Therapies: Current Status and Challenges | Immunostep Biotech","description":"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.-Cell therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/","og_locale":"es_ES","og_type":"article","og_title":"Off-the-Shelf Cell Therapies: Current Status and Challenges | Immunostep Biotech","og_description":"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.-Cell therapies.","og_url":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/","og_site_name":"Immunostep Biotech","article_publisher":"https:\/\/www.facebook.com\/immunostepsl\/","article_published_time":"2026-04-28T07:58:07+00:00","article_modified_time":"2026-04-07T08:31:39+00:00","og_image":[{"width":290,"height":174,"url":"https:\/\/immunostep.com\/wp-content\/uploads\/2026\/04\/Off-the-Shelf-Cell-Therapies-1.jpg","type":"image\/jpeg"}],"author":"\u00c1ngela Cabestrero","twitter_card":"summary_large_image","twitter_creator":"@Immunostep","twitter_site":"@Immunostep","twitter_misc":{"Escrito por":"\u00c1ngela Cabestrero","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#article","isPartOf":{"@id":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/"},"author":{"name":"\u00c1ngela Cabestrero","@id":"https:\/\/immunostep.com\/#\/schema\/person\/6f7086a7900eb41588a2465bcae5f427"},"headline":"Off-the-Shelf Cell Therapies: Current Status and Challenges","datePublished":"2026-04-28T07:58:07+00:00","dateModified":"2026-04-07T08:31:39+00:00","mainEntityOfPage":{"@id":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/"},"wordCount":435,"publisher":{"@id":"https:\/\/immunostep.com\/#organization"},"image":{"@id":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/immunostep.com\/wp-content\/uploads\/2026\/04\/Off-the-Shelf-Cell-Therapies-1.jpg","keywords":["#AllogeneicCells","#AutologousCells","#CellTherapy","#HLAEditing","#ImmuneEvasion","#OffTheShelfTherapy","#RegenerativeMedicine","#UniversalCells","CAR T","immunotherapy"],"articleSection":["Immunology"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/","url":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/","name":"Off-the-Shelf Cell Therapies: Current Status and Challenges | Immunostep Biotech","isPartOf":{"@id":"https:\/\/immunostep.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#primaryimage"},"image":{"@id":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/immunostep.com\/wp-content\/uploads\/2026\/04\/Off-the-Shelf-Cell-Therapies-1.jpg","datePublished":"2026-04-28T07:58:07+00:00","dateModified":"2026-04-07T08:31:39+00:00","description":"At Immunostep we have been innovating since 2001 to develop comprehensive products that contribute to improve.-Cell therapies.","breadcrumb":{"@id":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#primaryimage","url":"https:\/\/immunostep.com\/wp-content\/uploads\/2026\/04\/Off-the-Shelf-Cell-Therapies-1.jpg","contentUrl":"https:\/\/immunostep.com\/wp-content\/uploads\/2026\/04\/Off-the-Shelf-Cell-Therapies-1.jpg","width":290,"height":174,"caption":"Off-the-Shelf Cell Therapies"},{"@type":"BreadcrumbList","@id":"https:\/\/immunostep.com\/2026\/04\/28\/off-the-shelf-cell-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/immunostep.com\/es\/"},{"@type":"ListItem","position":2,"name":"Off-the-Shelf Cell Therapies: Current Status and Challenges"}]},{"@type":"WebSite","@id":"https:\/\/immunostep.com\/#website","url":"https:\/\/immunostep.com\/","name":"Immunostep Biotech","description":"Innovating to deliver high-performance technology for Research and Diagnosis","publisher":{"@id":"https:\/\/immunostep.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/immunostep.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/immunostep.com\/#organization","name":"Immunostep Biotech","url":"https:\/\/immunostep.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/immunostep.com\/#\/schema\/logo\/image\/","url":"https:\/\/immunostep.com\/wp-content\/uploads\/2021\/10\/logo-web-color.png","contentUrl":"https:\/\/immunostep.com\/wp-content\/uploads\/2021\/10\/logo-web-color.png","width":1299,"height":591,"caption":"Immunostep Biotech"},"image":{"@id":"https:\/\/immunostep.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/immunostepsl\/","https:\/\/x.com\/Immunostep","https:\/\/www.linkedin.com\/company\/immunostepsl\/"]},{"@type":"Person","@id":"https:\/\/immunostep.com\/#\/schema\/person\/6f7086a7900eb41588a2465bcae5f427","name":"\u00c1ngela Cabestrero","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/immunostep.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/378033e78b9b0300f6f50aeac830c5cf?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/378033e78b9b0300f6f50aeac830c5cf?s=96&d=mm&r=g","caption":"\u00c1ngela Cabestrero"},"url":"https:\/\/immunostep.com\/es\/author\/acabestrero\/"}]}},"_links":{"self":[{"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/posts\/39673"}],"collection":[{"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/users\/225"}],"replies":[{"embeddable":true,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/comments?post=39673"}],"version-history":[{"count":1,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/posts\/39673\/revisions"}],"predecessor-version":[{"id":39678,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/posts\/39673\/revisions\/39678"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/media\/39676"}],"wp:attachment":[{"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/media?parent=39673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/categories?post=39673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/immunostep.com\/es\/wp-json\/wp\/v2\/tags?post=39673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}